N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic SchizophreniaMehdi Farokhnia, Shahin Akhondzadeh, Anita Azarkolah et al.|Clinical Neuropharmacology|2013Cited by 154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trialMehdi Farokhnia, Shahin Akhondzadeh, Habibeh Yekehtaz et al.|Human Psychopharmacology Clinical and Experimental|2014Cited by 151
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patientsNazila Shahmansouri, Shahin Akhondzadeh, Mehdi Farokhnia et al.|Journal of Affective Disorders|2013Cited by 135
Cardiovascular considerations in antidepressant therapy: an evidence-based review.Habibeh Yekehtaz, Shahin Akhondzadeh, Mehdi Farokhnia|PubMed|2013Cited by 108
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled studyShahin Akhondzadeh, Omid Mirshafiee, Mehdi Farokhnia et al.|Psychiatry Research|2014Cited by 104